Palo Alto Investors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Palo Alto Investors’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-62,700	Closed	-$1.5M	–	49
2014 Q4	$1.5M	Hold	62,700	–	–	0.09%	40
2014 Q3	$1.58M	Hold	62,700	–	–	0.12%	37
2014 Q2	$1.64M	Hold	62,700	–	–	0.12%	39
2014 Q1	$1.62M	Hold	62,700	–	–	0.13%	32
2013 Q4	$1.27M	Hold	62,700	–	–	0.12%	31
2013 Q3	$1.64M	Sell	62,700 -20,900	-25%	-$523K	0.17%	30
2013 Q2	$1.84M	Buy	+83,600	New	+$1.83M	0.22%	29

Other funds holding HPTX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Palo Alto Investors's HPTX Position: Q1 2015 in Review

Palo Alto Investors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q1 2015, closing a stake of 62,700 shares — an estimated $1.5M sold.

Palo Alto Investors first reported a position in HPTX in Q2 2013 and held it in 7 quarters. The position peaked at $1.84M in Q2 2013. 134 funds tracked by Wall St. Rank hold HPTX as of Q1 2015.

Palo Alto Investors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
Palo Alto Investors sold 62,700 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q1 2015, an estimated $1.5M.
Palo Alto Investors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 7 quarters.
Palo Alto Investors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.84M in Q2 2013.
134 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q1 2015.

Based on Palo Alto Investors's 13F filing for Q1 2015, filed 15 May 2015.